Vitiligo during Treatment of Crohn’s Disease with Adalimumab: Adverse Effect or Co-Occurrence

Publisher: Karger

E-ISSN: 1662-6567|3|1|28-31

ISSN: 1662-6567

Source: Case Reports in Dermatology, Vol.3, Iss.1, 2011-02, pp. : 28-31

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract